BridgeBio Pharma, Inc.: Form SCHEDULE 13D/A, filed Aug 17, 2026
Filed with the SEC on Aug 17, 2026 and accepted by EDGAR at Aug 17, 2026, 17:30 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001140361-26-033404. Last ingested by Listed: Oct 29, 2026, 19:20 ET. Listed shows no prices and gives no investment advice.